These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH. Watkins WJ; Chen JM; Cho A; Chong L; Collins N; Fardis M; Huang W; Hung M; Kirschberg T; Lee WA; Liu X; Thomas W; Xu J; Zeynalzadegan A; Zhang J Bioorg Med Chem Lett; 2006 Jul; 16(13):3479-83. PubMed ID: 16621550 [TBL] [Abstract][Full Text] [Related]
8. In silico design of human IMPDH inhibitors using pharmacophore mapping and molecular docking approaches. Li RJ; Wang YL; Wang QH; Wang J; Cheng MS Comput Math Methods Med; 2015; 2015():418767. PubMed ID: 25784957 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory action of polyunsaturated fatty acids on IMP dehydrogenase. Mizushina Y; Dairaku I; Yanaka N; Takeuchi T; Ishimaru C; Sugawara F; Yoshida H; Kato N Biochimie; 2007 May; 89(5):581-90. PubMed ID: 17383068 [TBL] [Abstract][Full Text] [Related]
10. A three-dimensional pharmacophore model for IMPDH inhibitors. Yang N; Wang J; Li J; Wang QH; Wang Y; Cheng MS Chem Biol Drug Des; 2011 Jul; 78(1):175-82. PubMed ID: 21507206 [TBL] [Abstract][Full Text] [Related]
11. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery. Nair V; Shu Q Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958 [TBL] [Abstract][Full Text] [Related]
12. Novel indole-based inhibitors of IMPDH: introduction of hydrogen bond acceptors at indole C-3. Watterson SH; Dhar TG; Ballentine SK; Shen Z; Barrish JC; Cheney D; Fleener CA; Rouleau KA; Townsend R; Hollenbaugh DL; Iwanowicz EJ Bioorg Med Chem Lett; 2003 Apr; 13(7):1273-6. PubMed ID: 12657262 [TBL] [Abstract][Full Text] [Related]
13. Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitors. Birch HL; Buckley GM; Davies N; Dyke HJ; Frost EJ; Gilbert PJ; Hannah DR; Haughan AF; Madigan MJ; Morgan T; Pitt WR; Ratcliffe AJ; Ray NC; Richard MD; Sharpe A; Taylor AJ; Whitworth JM; Williams SC Bioorg Med Chem Lett; 2005 Dec; 15(23):5335-9. PubMed ID: 16202581 [TBL] [Abstract][Full Text] [Related]
14. A probable means to an end: exploring P131 pharmacophoric scaffold to identify potential inhibitors of Cryptosporidium parvum inosine monophosphate dehydrogenase. Omolabi KF; Iwuchukwu EA; Agoni C; Olotu FA; Soliman MES J Mol Model; 2021 Jan; 27(2):35. PubMed ID: 33423140 [TBL] [Abstract][Full Text] [Related]
15. Computational insights into the inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid analogs: three-dimensional quantitative structure-activity relationship and molecular docking studies. Yang N; Wang J; Wang ZW; Wang QH; Yang HG; Wang XJ; Cheng MS Chem Biol Drug Des; 2012 Jun; 79(6):1063-71. PubMed ID: 22405057 [TBL] [Abstract][Full Text] [Related]
16. Discovery of VHR phosphatase inhibitors with micromolar activity based on structure-based virtual screening. Park H; Jung SK; Jeong DG; Ryu SE; Kim SJ ChemMedChem; 2008 Jun; 3(6):877-80. PubMed ID: 18236492 [No Abstract] [Full Text] [Related]
17. Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening. Sarwono AEY; Mitsuhashi S; Kabir MHB; Shigetomi K; Okada T; Ohsaka F; Otsuguro S; Maenaka K; Igarashi M; Kato K; Ubukata M J Enzyme Inhib Med Chem; 2019 Dec; 34(1):171-178. PubMed ID: 30451014 [TBL] [Abstract][Full Text] [Related]
18. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents. Shah CP; Kharkar PS Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117 [TBL] [Abstract][Full Text] [Related]
20. IMPDH as a biological probe for RNA antiviral drug discovery: synthesis, enzymology, molecular docking, and antiviral activity of new ribonucleosides with surrogate bases. Nair V; Ma X; Shu Q; Zhang F; Uchil V; Cherukupalli GR Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):651-4. PubMed ID: 18066873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]